ocular hypertension (Q9294051)
eye disease that is characterized by elevated intraocular pressure in the absence of optic nerve damage or visual field loss
Language:
Current Data About ocular hypertension
(P31) (Q112193867)

(P279) (Q3041498)
(P813) Saturday, July 28, 2018
(P248)
(P5270) MONDO_0006875

(Q95566669)

(Q12136)

(P1552) (Q63345803)
(P642)

(P1692) 365.04
(P248)
(P813) Wednesday, May 15, 2019
(P699) DOID:9282

(P1748) C3285
(P248)
(P813) Wednesday, May 15, 2019
(P699) DOID:9282

(P1995) (Q161437)

(P2176) (Q905952)
(P248)
(P2115) N0000147820
(P407)
(P813) Tuesday, December 13, 2016

(Q577377)
(P248)
(P2115) N0000022048
(P407)
(P813) Tuesday, December 13, 2016

(Q4781812)
(P248)
(P2115) N0000148534
(P407)
(P813) Tuesday, December 13, 2016

(Q408556)
(P248)
(P2115) N0000147888
(P407)
(P813) Tuesday, December 13, 2016

(Q4859684)
(P248)
(P2115) N0000022210
(P407)
(P813) Tuesday, December 13, 2016

(Q413994)
(P248)
(P2115) N0000148034
(P407)
(P813) Tuesday, December 13, 2016

(Q2193376)
(P248)
(P2115) N0000148702
(P407)
(P813) Tuesday, December 13, 2016

(Q634959)
(P248)
(P2115) N0000148440
(P407)
(P813) Tuesday, December 13, 2016

(Q794162)
(P248)
(P2115) N0000147726
(P407)
(P813) Tuesday, December 13, 2016

(Q407646)
(P248)
(P2115) N0000146108
(P407)
(P813) Tuesday, December 13, 2016

(Q2393348)
(P248)
(P2115) N0000148703
(P407)
(P813) Tuesday, December 13, 2016

(Q546434)
(P248)
(P2115) N0000147523
(P407)
(P813) Tuesday, December 13, 2016

(Q48318)
(P248)
(P2115) N0000146756
(P407)
(P813) Tuesday, December 13, 2016

(Q27106078)
(P248)
(P2115) N0000148291
(P407)
(P813) Tuesday, December 13, 2016

(Q5299119)
(P248)
(P813) Tuesday, October 2, 2018

(Q411517)
(P248)
(P813) Tuesday, October 2, 2018

(Q27078867)
(P580) Wednesday, November 1, 2017
(P790)
(P248)
(P813) Friday, November 2, 2018
(P854) https://drugs.ncats.io/drug/EJ85341990
https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/207795Orig1s000lbl.pdf

(Q4859684)
(P580) Thursday, August 3, 2000
(P790)
(P248)
(P813) Friday, November 2, 2018
(P854) https://drugs.ncats.io/drug/6X4F561V3W
https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021214s006s007lbl.pdf

(Q411517)
(P580) Wednesday, April 1, 1998
(P790)
(P248)
(P813) Friday, November 2, 2018
(P854) https://drugs.ncats.io/drug/9451Z89515
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e9ea2ae7-1b98-4034-9fba-8ce2225e0145

(Q6593346)
(P580) Friday, December 29, 1989
(P790)
(P248)
(P813) Friday, November 2, 2018
(P854) https://drugs.ncats.io/drug/X39AL81KEB
https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=699ce415-0798-4244-b5ec-bcdb383b50b3&type=display

(Q27280492)
(P580) Friday, February 10, 2017
(P790)
(P248)
(P813) Friday, November 2, 2018
(P854) https://drugs.ncats.io/drug/I6393O0922
https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/207795Orig1s000lbl.pdf

(P2888) http://purl.obolibrary.org/obo/DOID_9282
(P248)
(P813) Monday, November 30, 2020
(P699) DOID:9282

http://identifiers.org/doid/DOID:9282
(P248)
(P854) https://registry.identifiers.org/registry/doid

(P5008) (Q4099686)

other details
aliases ocular hypertension (disorder)
description eye disease that is characterized by elevated intraocular pressure in the absence of optic nerve damage or visual field loss

External Links
(P486) D009798
(P557) 5226
(P672) C11.525
(P673) 1207470
(P699) DOID:9282
(P2892) C0028840
C0017614
(P3827) ocular-hypertension
(P4229) H40.05
(P4233) ocular-hypertension
(P5270) MONDO_0006875
(P6366) 2776521421
(P10283) C2776521421
C2910015228
(P11143) Ocular hypertension
(P11956) 1001069